Proposed pathogenesis, characteristics, and management of COVID-19 mRNA vaccine-related myopericarditis

A Hajra, M Gupta, B Ghosh, K Ashish, N Patel… - American Journal of …, 2022 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel coronavirus
causing coronavirus disease 2019 (COVID-19), has affected human lives across the globe …

Myocarditis after COVID‐19 mRNA vaccination: A systematic review of case reports and case series

DY Park, S An, A Kaur, S Malhotra, A Vij - Clinical Cardiology, 2022 - Wiley Online Library
Background The coronavirus disease of 2019 (COVID‐19) is a global pandemic with over
266 million cases and 5 million deaths worldwide. Anti‐COVID‐19 vaccinations have had …

[HTML][HTML] Case report: acute fulminant myocarditis and cardiogenic shock after messenger RNA coronavirus disease 2019 vaccination requiring extracorporeal …

Y Lim, MC Kim, KH Kim, IS Jeong, YS Cho… - Frontiers in …, 2021 - frontiersin.org
Recently, myocarditis following mRNA COVID-19 vaccination has become an important
social issue in worldwide. According to the reports so far, mRNA COVID-19 vaccination …

Acute myocarditis after COVID‐19 vaccination with mRNA‐1273 in a patient with former SARS‐CoV‐2 infection

TD Nguyen, G Mall, JG Westphal… - ESC heart …, 2021 - Wiley Online Library
We describe a case of a 20‐year‐old healthy man developing chest pain and classical
symptoms of vaccine reactogenicity 12 h after receiving the first dose of mRNA‐1273 …

Myocarditis associated with COVID-19 and its vaccines-a systematic review

A Rout, S Suri, M Vorla, DK Kalra - Progress in Cardiovascular Diseases, 2022 - Elsevier
Since the beginning of the COVID-19 (Coronavirus Disease of 2019) pandemic, myocarditis
has received much attention and controversy as one of the more worrisome cardiovascular …

Novel pro-and eukaryotic expression plasmid expressing omicron antigens delivered via Salmonella elicited MHC class I and II based protective immunity

C Sivasankar, C Hewawaduge, JH Lee - Journal of Controlled Release, 2023 - Elsevier
The latest omicron variants are emerging with mutations in the receptor binding domain
(RBD) that confer immune evasion and resistance against current vaccines. Such variants …

[HTML][HTML] Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the …

C Chen, F Fu, L Ding, J Fang, J Xiao - Frontiers in immunology, 2022 - frontiersin.org
Background Despite the likely association between coronavirus 2019 (COVID-19) mRNA
vaccines and cases of myocarditis/pericarditis, the benefit–risk assessment by the Centers …

[HTML][HTML] Acute myocarditis following mRNA-1273 SARS-CoV-2 vaccination

CB Williams, J Choi, F Hosseini, J Roberts… - CJC open, 2021 - Elsevier
Myocarditis has been described previously as a rare side effect of both influenza and
smallpox vaccines. In this report, we present a case of acute perimyocarditis in a young …

No correlation between anti-PF4 and anti–SARS-CoV-2 antibodies after ChAdOx1 nCoV-19 vaccination

G Uzun, K Althaus, T Bakchoul - New England Journal of …, 2021 - Mass Medical Soc
Pathogenic Antibodies in Patients with VITT Vaccine-induced immune thrombotic
thrombocytopenia is caused by the induction of anti-PF4 polyanion antibodies in response …

Cardiovascular complications of COVID-19 vaccines: A review of case-report and case-series studies

MH Paknahad, FB Yancheshmeh, A Soleimani - Heart & Lung, 2023 - Elsevier
Background There are multiple reviews on cardiovascular aspects of COVID-19 disease on
cardiovascular system in different population but there is lack of evidence about …